Foolish Forecast: Don't Touch DTS

Recs

3

Thursday night is earnings night for digital-entertainment technologist DTS (Nasdaq: DTSI). Are we looking for a scrambled signal or pure digital clarity in the fourth quarter? Read on, and all will be clear.

What Fools say:
Here's how DTS's CAPS rating stacks up against some of its peers and competitors:

Market Cap (millions)

Trailing P/E Ratio

CAPS Rating (out of 5)

Sony (NYSE: SNE)

$49,060

20.4

**

Dolby Laboratories (NYSE: DLB)

$5,167

33.0

*****

National CineMedia (Nasdaq: NCMI)

$902

56.0

**

DTS

$414

N/M

*

SRS Labs (Nasdaq: SRSL)

$71

12.5

*****

Data taken from Motley Fool CAPS on Feb. 27.

The only CAPS comment on this stock since last May comes from a grumpy bear, who thinks that the company is "trying to figure itself out." In the last five months, there have been five "outperform" calls on DTS and 11 "underperform" calls. The thumbs-down ratings have been the good ones.

What management does:

Margins

6/2006

9/2006

12/2006

3/2007

6/2007

9/2007

Gross

84.7%

89.7%

75.7%

73.1%

74.6%

75.3%

Operating

21.3%

21.6%

4.9%

(7.0%)

(3.1%)

(0.6%)

Net

17.4%

16.2%

3.9%

(6.8%)

(9.9%)

(10.1%)

FCF/Revenue

17.6%

16.1%

(2.1%)

(21.8%)

(19.0%)

(14.1%)

Growth (YOY)

6/2006

9/2006

12/2006

3/2007

6/2007

9/2007

Revenue

(9.2%)

(22.0%)

4.1%

(4.9%)

11.9%

29.6%

All data courtesy of Capital IQ, a division of Standard & Poor's. Data reflects trailing-12-month performance for the quarters ended in the named months.

One Fool says:
You might think that a company with a finger in just about every DVD player sold, as well as a lot of the shiny discs that go in them, would be rolling in moolah. You'd be wrong, though. DTS makes no more than $10 million to $20 million in revenue per quarter, and spends about as much on operating expenses. It doesn't generate reliable cash flow, and it doesn't offer predictable growth, as seen above.

If you're interested in DTS because you like the underlying technology, your investment dollars would be in much safer hands with Dolby. Take all the bad things I just said about DTS, turn them around 180 degrees, and you get Dolby's model of efficiency, with strong cash flows and accelerating growth. That's what I'd call a good investment.

Sorry, DTS. You're losing this two-horse race. There just aren't any business catalysts that could push DTS into the same league as the competition. The company has missed Wall Street's targets in two of the last five quarters, and I can smell another disappointment coming up.

Closed for 15 months – opening 10 days only! Get notified ahead of time as our expert portfolio manager invests $1 MILLION in the best opportunities from across The Motley Fool’s premium investment services. This is the first open since August 2008, by invitation only. Enter email below.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 586757, ~/Articles/ArticleHandler.aspx, 11/10/2009 7:02:01 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

11/9/2009 4:02 PM
DLB $42.70 Up +0.84 +2.01%
Dolby Laboratories… CAPS Rating: *****
SNE $29.49 Up +0.62 +2.15%
Sony Corp (ADR) CAPS Rating: **
DTSI $30.83 Up +0.58 +1.92%
DTS, Inc. CAPS Rating: *

Community: Investing Wiki

Term Of The Hour

Biotechnology: Biotechnology uses biological processes to solve problems in such areas as health and medicine, agriculture and manufacturing.

Want to learn more or edit this definition?
Click here to read more!